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SHORT COMMUNICATION
Expression of MHC class II, interleukin 2 receptor and CD45 antigens
on tumour-associated T lymphocytes in colonic carcinoma
M.N. Norazmi', A.W. Hohmann', J.M. Skinner2 & J. Bradley',
'Department ofClinical Immunology, and 2Department ofHistopathology, Flinders Medical Centre, Bedford Park, South Australia
5042, Australia.
Mononuclear cells often infiltrate tumour tissue suggesting
that an immune response is generated against the tumours.
In colonic carcinomas (Csiba et al., 1984), breast carcinomas
(Rowe & Beverley, 1984) and melanomas (Ralfkiaer et al.,
1987), T lymphocytes have been found to be the predominant
mononuclear cell infiltrate. In colonic carcinomas we have
shown that the tumour-associated T lymphocytes (TATL)
carrying the CD4 phenotype predominanted over the CD8 +
cells by a ratio of three to one (submitted for publication).
Since T lymphocytes are a normal component of the colon
it is not clear to what extent the cells surrounding a tumour
are committed to tumour reaction. To give some insight into
this problem, we investigated the expression of certain T
lymphocyte activation markers, including the major histo-
compatibility complex (MHC) class II antigens (HLA-DR,
-DP, -DQ) and the interleukin 2 receptor (IL2R), on TATL
surrounding colonic tumours. Furthermore, using mono-
clonal antibodies (mAb) against the CD45 antigen (leucocyte
common antigen, LCA) we attempted to define distinct
subsets of the CD4 + cells in the tumours.
Eighteen fresh frozen or paraffin-embedded tissue sections
obtained from patients with colonic carcinoma were used.
This comprised four stage A, five stage B, five stage C and
four stage D tumours where staging was determined by the
Australian Clinico-Pathological Staging System as described
by Davis and Newland (1983). These tissues were reacted
with mouse mAb (Table I) and their binding revealed using
the avidin-biotin horseradish peroxidase complex (ABC)
staining technique (Hsu et al., 1981) employing diaminoben-
zidine as the substrate. As the mAb used to define the two
epitopes of the LCA family, UCHL1 and FMC44, react with
Table I List of monoclonal antibodies used
Antibody
designation Specificity Source
L243 monomorphic HLA-DR molecules BD
(Lampson & Levy, 1980)
B7/21 monomorphic HLA-DP molecules IT
(Royston et al., 1981)
LeulO monomorphic HLA-DQ molecules BD
(Chen et al., 1984)
anti-Tac low affinity IL2R (Dower et al., 1985) BD
UCHLI 180 kDa component of LCA family Dakopatts
(Smith et al., 1986)
FMC44 220/205 kDa component of LCA family FMC
(CD45R) (Dr H. Zola, personal
communication)
Leu4 pan-T cell (CD3) (Ledbetter et al., 1981) BD
BD, Becton Dickinson, Burlingame, CA, USA; Dakopatts,
Dakopatts a/s, Glostrup, Denmark; FMC, Flinders Medical Centre,
Dept. of Clinical Immunology; IT, Gift from Dr I. Trowbridge.
Correspondence: A.W. Hohmann.
Received 7 December 1988; and in revised form 10 May 1989.
formalin-fixed tissues, we used such tissue with these two
mAb. In frozen sections the total number of infiltrating
leucocytes were identified using a pan-leucocyte marker
(FMC 51). In formalin-fixed tissue the amount of the mono-
nuclear cell infiltrate was identified histologically. The pro-
portion of these cells expressing the activation markers was
determined using a qualitative scoring system. This system
assigned the following values depending on the relative
number of cells stained: 0 = no cells stained (similar to nega-
tive control); 1 = few and/or sparse; 2 = moderate numbers;
3 = dense; 4 = very dense (i.e. nearly all mononuclear cells
stained). Figure 1 summarises the results of this study.
We had previously found that there was a significant
reduction in the total number of T lymphocytes in late stage
tumours compared to the good prognostic stage A tumours
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Figure 1 Expression of activation antigens on tumour-associated
lymphocytes. Cryostat sections of human colonic carcinomas
were reacted with mouse mAb and stained by the immunoperox-
idase technique. The relative number of cells stained with each
mAb was scored on a scale of 0-4 where: 0 = no cells (similar to
negative control); I = few and/or sparse; 2 = moderate numbers;
3 = dense; 4 = very dense. 'These cases were obtained from
formalin-fixed paraffin-embedded tissues. Previous results showed
that the reactivities of the mAb, UCHLI and FMC44 were not
markedly different from fresh frozen tissue sections.
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and a considerable variability in this total number occurred
between individual cases. Our interest in this paper was thus
not to compare the total number of infiltrating cells but to
identify changes which occur in the phenotype of these cells
with tumour stage. Thus we chose to represent the results as
a relative cell density which is related to the total number of
mononuclear cells present in a tissue.
Expression ofMHC class II
In 16 of the 18 cases studied, HLA-DR positive cells were
present in high densitites (score 3.5-4). The remaining two
cases were scored with a moderate density of DR positive
cells. In a previous work we had found that most of the
tumour-associated mononuclear cells were T cells (CD3 + ).
Although B cells were not found in any of the 18 cases,
macrophages comprised approximately one-third of the
TAMC in a small number of cases. Thus, these macrophages
would have accounted for some of the class II positive cells.
However, using a dual immunoenzyme labelling system
(Hohmann et al., 1988) we demonstrated that all CD3 +
cells expressed DR.
HLA-DP cells were found in high density in 14 of 18 cases
(score 3-3.5) and in moderate density in the remaining four
cases (score 1.5-2.0). Cells expressing DR and DP were
present in all cases and neither their presence nor relative
density showed any relation to tumour stage.
Although only four stage D tumours were available, three
of these were HLA-DQ negative and were the only HLA-DQ
negative cases of the 18 tumours examined. Although based
on a small sample size, this finding may be of some signi-
ficance since not only during ontogeny are the class II
antigens differentially expressed (Edwards et al., 1985) but
cells expressing different class II gene products appear to play
different roles in immune responses (Natali et al., 1986). In
particular, HLA-DQ + T cells have been reported to be
important in effector functions (Navarrete et al., 1986) and a
DQwl mAb has been shown to block the generation of
cytotoxic T cells in a mixed-lymphocyte reaction (MLR)
(Corte et al., 1982).
In those three cases lacking HLA-DQ + cells, the infil-
trating cells expressed other 'activation' markers and the
total number of infiltrating cells, although reduced in number
from that of stage A tumours, was not significantly different
from stage B or C tumours where HLA-DQ + cells were
readily found.
Expression ofIL2R
Ralfkiaer et al. (1987) reported that most of the T lym-
phocyte infiltrate in malignant melanomas expressed the
IL2R. However, in our study IL2R + TATL were present in
only low density (score ( 1) and only in four of the 18 cases.
The lack of reactivity with the anti-IL2R mAb on its own
could not rule out the presence of IL2R on the TATL. The
anti-Tac mAb reacts only with the low affinity IL2R and the
presence of the high affinity IL2R cannot be excluded using
this mAb (Smith, 1988). Furthermore, interleukin 2 released
by the TATL and bound to the IL2R on these cells may
block the reactivity of this mAb (Leonard et al., 1983).
Expression ofCD45
In all cases cells expressing the p180 antigen were present
while CD45R + (p220) cells were found in only five of the 18
cases. These five cases consisted of one stage A, one stage B,
two stage C and one stage D case. From other works which
have investigated the expression of the CD45 antigens on T
cells it appears that cells progress from expression of the
CD45R epitope to the p180 epitope as a consequence of
activation and that p180 + cells represent a primed/memory
subset of T cells (Akbar et al., 1988; Serra et al., 1988). If
this hypothesis is correct, our findings indicate that the
p180 + cells are primed or 'committed' effector cells within
the tumour tissue. However, the predominance of p180+
cells may be due to the recruitment of these cells into the
tumours.' This is suggested by the work of Pitzalis et al.
(1988), who showed that p180 + cells preferentially accumu-
lated in inflammatory lesions. As p180 + and p220 + cells
have distinct requirements for lymphokines (Greenbaum et
al., 1988), their recruitment may be influenced by the release
of cytokines by other tumour-associated mononuclear cells.
In summary, it appears that most of the TATL in colonic
carcinomas may be primed and activated T cells by virtue of
their expression of the class II antigens and the p180 antigen.
Conversely, there may have been a preferential infiltration of
the distinct subset of CD4 + /UCHL1 + T cells into the
tumour site. The lack of IL2R was unexpected. The absence
of HLA - DQ + TATL only in stage D tumours suggests
that HLA - DQ + may be an important marker for a type
of T cell involved in effective tumour reactions and warrants
further investigation in more late stage tumours.
Mr M.N. Norazmi is supported by the Universiti Sains Malaysia.
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